Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Renin Inhibition and the Kidney

NCT01217736 is registered in ClinicalTrials.gov with Vitae Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01217736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01217736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Renin Inhibition and the Kidney
Lead sponsor
Vitae Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2010
Completion date
November 30, 2011
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal function